The evaluation of dehydroepiandrosterone sulfate non-small cell lung cancer patients

D. Dworakowska, M. Lapinski, D. Tomaszewski, J. Skokowski, W. Rzyman, E. Czestochowska, K. Sworczak (Poland)

Source: Annual Congress 2006 - Lung cancer, haemoptoe, smoking and COPD
Session: Lung cancer, haemoptoe, smoking and COPD
Session type: E-Posters in free access
Number: 348
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Dworakowska, M. Lapinski, D. Tomaszewski, J. Skokowski, W. Rzyman, E. Czestochowska, K. Sworczak (Poland). The evaluation of dehydroepiandrosterone sulfate non-small cell lung cancer patients. Eur Respir J 2006; 28: Suppl. 50, 348

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum level of GFBP-1 and IGFBP-6 in patients with non-small cell lung cancer (NSCLC) during chemotherapy
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009


Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 771s
Year: 2006

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
Source: Eur Respir Rev 2015; 25: 65-70
Year: 2016



Advanced non-small cell lung cancer in elderly patients
Source: Breathe 2012; 9: 26-34
Year: 2012

Soluble non-invasive markers in non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 459s
Year: 2005

Serum level of IGF-I and IGF-II in patients with non-small cell lung cancer (NSCLC) during chemotherapy
Source: Eur Respir J 2004; 24: Suppl. 48, 82s
Year: 2004

Expression of sex hormone receptors in non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004

Radiotherapy in the treatment of nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 207–243
Year: 2009

Combined radiotherapy for nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 31s
Year: 2003

Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Effect of comorbidity on the prognosis of non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 385s
Year: 2006

New treatment options for nonsmall cell lung cancer and small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006

Update on nonsmall cell lung cancer
Source: Eur Respir Rev 2010 19: 173-185
Year: 2010


Anticancer treatment for advanced non-small cell lung cancer
Source: Breathe 2011; 8: 124-133
Year: 2011


Targeted therapy in non-small cell lung cancer
Source: Breathe 2012; 8: 206-215
Year: 2012

Plasma leptin levels in nonsmall cell lung carcinoma (NSCLC) patients at the time of the diagnosis
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001

Second line therapy for advanced non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Results of surgical treatment in elderly patients with non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 463s
Year: 2002

Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010